SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.67 0.16
(0.19%)

EUR-INR

102.19 -0.14
(-0.14%)

GBP-INR

115.88 -0.12
(-0.10%)

JPY-INR

0.56 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Corporate Results - Detailed News

EQUITY - MARKET SCREENER

Back

Mangalam Drugs and Organics reports consolidated net loss of Rs 7.35 crore in the September 2025 quarter

21-Nov-25 07:43 Hrs IST

Net loss of Mangalam Drugs and Organics reported to Rs 7.35 crore in the quarter ended September 2025 as against net profit of Rs 2.69 crore during the previous quarter ended September 2024. Sales declined 38.23% to Rs 49.26 crore in the quarter ended September 2025 as against Rs 79.75 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	49.26	79.75	-38
OPM %	-5.77	10.91	-
PBDT	-7.84	5.17	PL
PBT	-12.47	1.20	PL
NP	-7.35	2.69	PL

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.67 0.16 (0.19%)

102.19 -0.14 (-0.14%)

115.88 -0.12 (-0.10%)

0.56 0.00 (-0.65%)